Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02279082 · ClinicalTrials.gov registry record · Phase 3
DFN-02 Open Label Safety Study in Patients With Acute Migraine
A Phase 3 study, sponsored by Dr. Reddy's Laboratories Limited.
- Completed
- Registry status
- Phase 3
- Development phase
- 167
- Enrollment target
NCT02279082: Completed Phase 3 study, sponsored by Dr. Reddy's Laboratories Limited.
NCT02279082 is a Phase 3 study that has completed, run by Dr. Reddy's Laboratories Limited. The registered enrollment target is 167 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02279082, a Phase 3 study, has completed, sponsored by Dr. Reddy's Laboratories Limited.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 167 participants
- Enrollment target
Study Summary
A multi-center, open-label, safety study of DFN-02 for the Treatment of Acute Migraines
Interventions
- DRUG DFN-02
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 167 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-03 |
| Phase | Phase 3 |
What the finished NCT02279082 record still lists
NCT02279082 is an interventional study that assigns participants to a tested intervention. The registered 167 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 1 intervention - of which DFN-02 is the first listed.
NCT02279082 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02279082 about?
NCT02279082 is a clinical study titled "DFN-02 Open Label Safety Study in Patients With Acute Migraine". A multi-center, open-label, safety study of DFN-02 for the Treatment of Acute Migraines
What is the current status of trial NCT02279082?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 167 participants. The study started on 2014-09. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02279082?
The interventions under investigation include: DFN-02 (DRUG).
Who is sponsoring clinical trial NCT02279082?
This trial is sponsored by Dr. Reddy's Laboratories Limited, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02279082's enrollment target sits among peer trials
167 1463rd of 2000 higher than 538 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04248283 · 167 participants · NA
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
- NCT04552509 · 167 participants · NA
TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer
- NCT05516277 · 167 participants · NA
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
- NCT02118922 · 168 participants
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia